0001127602-24-010112.txt : 20240314 0001127602-24-010112.hdr.sgml : 20240314 20240314160342 ACCESSION NUMBER: 0001127602-24-010112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240313 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASPER MARC N CENTRAL INDEX KEY: 0001216055 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08002 FILM NUMBER: 24749680 MAIL ADDRESS: STREET 1: C/O THERMO FISHER SCIENTIFIC STREET 2: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC. CENTRAL INDEX KEY: 0000097745 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042209186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7816221000 MAIL ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: THERMO ELECTRON CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-13 0000097745 THERMO FISHER SCIENTIFIC INC. TMO 0001216055 CASPER MARC N 168 THIRD AVENUE WALTHAM MA 02451 1 1 Chairman & CEO 1 Common Stock 2024-03-13 4 M 0 10000 190.59 A 133816.462 D Common Stock 2024-03-13 4 S 0 300 591.82 D 133516.462 D Common Stock 2024-03-13 4 S 0 3593 593.01 D 129923.462 D Common Stock 2024-03-13 4 S 0 2172 594.02 D 127751.462 D Common Stock 2024-03-13 4 S 0 900 595.06 D 126851.462 D Common Stock 2024-03-13 4 S 0 1662 596.49 D 125189.462 D Common Stock 2024-03-13 4 S 0 1073 597.39 D 124116.462 D Common Stock 2024-03-13 4 S 0 300 597.99 D 123816.462 D Common Stock 11300 I By Alison Casper 2020 Irrevocable Trust Common Stock 43608 I By Floral Park Associates, Inc. Common Stock 5000 I By MNC 2020 Irrevocable Trust Stock Option (Right to Buy) 190.59 2024-03-13 4 M 0 10000 0 D 2021-03-07 2024-09-07 Common Stock 10000 56300 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $591.29 to $592.09, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $592.50 to $593.36, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $593.51 to $594.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.64 to $595.27, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.84 to $596.81, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.88 to $597.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $597.90 to $598.11, inclusive. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. /s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper 2024-03-14